# Two Rizatriptan Prescribing Portions for Treatment of Migraine

> **NCT00397254** · PHASE4 · COMPLETED · sponsor: **Clinvest** · enrollment: 197 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** rizatriptan
- **DRUG:** rizatriptan

## Key facts

- **NCT ID:** NCT00397254
- **Lead sponsor:** Clinvest
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2010-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397254, "Two Rizatriptan Prescribing Portions for Treatment of Migraine". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00397254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*